17-19387057-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000299610.5(MFAP4):c.6+93G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000411 in 1,521,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00035 ( 0 hom., cov: 28)
Exomes 𝑓: 0.00042 ( 0 hom. )
Consequence
MFAP4
ENST00000299610.5 intron
ENST00000299610.5 intron
Scores
2
14
Clinical Significance
Conservation
PhyloP100: 0.316
Genes affected
MFAP4 (HGNC:7035): (microfibril associated protein 4) This gene encodes a protein with similarity to a bovine microfibril-associated protein. The protein has binding specificities for both collagen and carbohydrate. It is thought to be an extracellular matrix protein which is involved in cell adhesion or intercellular interactions. The gene is located within the Smith-Magenis syndrome region. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.00643155).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MFAP4 | NM_002404.3 | c.6+93G>T | intron_variant | ENST00000299610.5 | NP_002395.1 | |||
MFAP4 | NM_001198695.2 | c.62G>T | p.Gly21Val | missense_variant | 1/6 | NP_001185624.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MFAP4 | ENST00000395592.6 | c.62G>T | p.Gly21Val | missense_variant | 1/6 | 1 | ENSP00000378957.2 | |||
MFAP4 | ENST00000299610.5 | c.6+93G>T | intron_variant | 1 | NM_002404.3 | ENSP00000299610.5 | ||||
MFAP4 | ENST00000571210.1 | n.41+93G>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000350 AC: 50AN: 142724Hom.: 0 Cov.: 28
GnomAD3 genomes
AF:
AC:
50
AN:
142724
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000443 AC: 110AN: 248096Hom.: 0 AF XY: 0.000469 AC XY: 63AN XY: 134366
GnomAD3 exomes
AF:
AC:
110
AN:
248096
Hom.:
AF XY:
AC XY:
63
AN XY:
134366
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000417 AC: 575AN: 1378572Hom.: 0 Cov.: 32 AF XY: 0.000413 AC XY: 283AN XY: 684554
GnomAD4 exome
AF:
AC:
575
AN:
1378572
Hom.:
Cov.:
32
AF XY:
AC XY:
283
AN XY:
684554
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000350 AC: 50AN: 142866Hom.: 0 Cov.: 28 AF XY: 0.000319 AC XY: 22AN XY: 69014
GnomAD4 genome
AF:
AC:
50
AN:
142866
Hom.:
Cov.:
28
AF XY:
AC XY:
22
AN XY:
69014
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
37
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.62G>T (p.G21V) alteration is located in exon 1 (coding exon 1) of the MFAP4 gene. This alteration results from a G to T substitution at nucleotide position 62, causing the glycine (G) at amino acid position 21 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Benign
T
Vest4
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at